Earlier presentation and application of curative treatments in hepatocellular carcinoma. - Wikidata - awgldk - TriplyDB

Earlier presentation and application of curative treatments in hepatocellular carcinoma.

Earlier presentation and application of curative treatments in hepatocellular carcinoma.

http://www.wikidata.org/entity/Q34416067

about

Strategies to improve outcome of patients with hepatocellular carcinoma receiving a liver transplantation MET inhibitors for treatment of advanced hepatocellular carcinoma: A review Liver transplantation for advanced hepatocellular carcinoma Impact of sustained viral response postcurative therapy of hepatitis C-related hepatocellular carcinoma: a systematic review and meta-analysis.Improved Outcomes Following Hepatocellular Carcinoma (HCC) Diagnosis in Patients Screened for HCC in a Large Academic Liver Center versus Patients Identified in the Community.Treatment of hepatocellular carcinoma in the community: disparities in standard therapy.Effectiveness of Initial Transarterial Chemoembolization for Hepatocellular Carcinoma Among Medicare Beneficiaries Bromodomain-containing protein 7 (BRD7) as a potential tumor suppressor in hepatocellular carcinoma Future of Hepatocellular Carcinoma Incidence in the United States Forecast Through 2030 PD-L1 expression as a predictive biomarker for cytokine-induced killer cell immunotherapy in patients with hepatocellular carcinoma.Sorafenib Effectiveness in Advanced Hepatocellular Carcinoma.Liver resection for early hepatocellular cancer: Comparison of centers in 3 different countries Trends and Predictors of Chemotherapy Use among Thyroid Cancer Patients in the National Cancer Database (2004-2013).LIVER TRANSPLANTATION FOR CARCINOMA HEPATOCELLULAR IN SÃO PAULO: 414 CASES BY THE MILAN/BRAZIL CRITERIA.HabibTM 4X-assisted resection versus clamp-crush resection for hepatocellular carcinoma: a propensity-matching study.Cost effectiveness of regorafenib as second-line therapy for patients with advanced hepatocellular carcinoma.Hospital Volume and Survival After Hepatocellular Carcinoma Diagnosis.PD-1 Checkpoint Blockade in Combination with an mTOR Inhibitor Restrains Hepatocellular Carcinoma Growth Induced by Hepatoma Cell-Intrinsic PD-1.Management and prognosis of hepatocellular carcinoma in the elderly: Results of an in-field multicenter cohort study.A SEER Database Analysis of the Survival Advantage of Transarterial Chemoembolization for Hepatocellular Carcinoma: An Underutilized Therapy.Complications and competing risks of death in compensated viral cirrhosis (ANRS CO12 CirVir prospective cohort).Combination of transcatheter arterial chemoembolization and interrupted dosing sorafenib improves patient survival in early-intermediate stage hepatocellular carcinoma: A post hoc analysis of the START trial.Comparison between liver resection and liver transplantation on outcomes in patients with solitary hepatocellular carcinoma meeting UNOS criteria: a population-based study of the SEER database.Evaluation of the treatment of the hepatocarcinoma nodules in the patients in waiting list for liver transplant.Hospice Utilization and Its Effect on Acute Care Needs at the End of Life in Medicare Beneficiaries With Hepatocellular Carcinoma.The immune contexture of hepatocellular carcinoma predicts clinical outcome.lncAKHE enhances cell growth and migration in hepatocellular carcinoma via activation of NOTCH2 signaling.Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study.Hepatocellular carcinoma and immune therapy, from a clinical perspective; where are we?High Expression of Glycolytic Genes in Cirrhosis Correlates With the Risk of Developing Liver Cancer

P2860

Q27005375-209C1D73-A19C-4E4C-8D29-E89E95370057 Q27014423-E420A6D0-B9DF-4A5F-8D0C-77E42500F483 Q28074653-9A89001A-84F6-459B-9D19-DBA2AB583182 Q30241048-A418F03B-50DE-408E-ADD9-C46C5F81A3AB Q33621628-0A8760C1-6539-4985-9728-B33CB9CAB050 Q35631429-682B3F7C-0C5F-47AB-A1AE-4D9BBACBAB2B Q36886453-C475F3D7-D5D9-4445-B017-9B6C06C852AF Q37086000-12AF7696-A5AD-4EBB-83FF-44F77B7B2EB5 Q37137944-D8F2FC95-BD28-4594-8939-F343FF31990B Q37222072-0925AD15-CF57-4A9E-B856-ACCB236718DA Q37242363-F53BD56C-E696-4A88-A02A-9F7DF9E2ADF5 Q37399648-AF56CD64-54E3-4875-A88F-341BD2282714 Q37562871-0154A6C5-1FDA-4BBC-8AE5-E4FC38910F85 Q37579484-F1CBA8ED-0CE8-45F7-99A2-770137737BC0 Q37706158-EFB98647-AE6A-4341-B483-14CCC784F242 Q38702281-1B5EDA8B-C344-44A6-97CC-A5621F052A4B Q39776912-1D8538FF-127A-41E4-880A-123A0522613A Q40124899-9D121D4F-8588-46B3-92AD-FCBD6572E973 Q40327172-04CC0446-2F3C-4FDB-AF9D-5C944CD17829 Q40431481-5BDBEA97-9646-4DFB-9AA4-98E44E9E5D73 Q41441593-BC2E5480-473C-4155-8A5B-1B1202BCC04E Q42360747-4F26A492-98FF-469D-A053-0DEF4818A018 Q47119768-0A144D94-CD81-46C2-8EA9-C13B2E50015F Q50093044-48771C55-3BA2-4751-BC8C-38BAABC1E489 Q52769099-C378C833-9E44-4365-9FFA-8B089894510F Q55180095-C2D4AB28-2743-44E2-8CB7-9EB4A4ED34E1 Q55181025-D20DFD67-1730-4180-922E-8FDFA271FB78 Q55715098-E197D6BD-6CEC-4E30-8599-2B5CD80F6DB2 Q56894760-3B1A2391-0D53-4D92-BE0B-E12BD2B9111B Q59133582-4DBB5CC9-8975-4F35-BF34-42A921BC03C6

P2860

Earlier presentation and application of curative treatments in hepatocellular carcinoma.

http://www.wikidata.org/entity/Q34416067

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Earlier presentation and application of curative treatments in hepatocellular carcinoma.

@ast

Earlier presentation and application of curative treatments in hepatocellular carcinoma.

@en

Earlier presentation and application of curative treatments in hepatocellular carcinoma.

@nl

type

label

Earlier presentation and application of curative treatments in hepatocellular carcinoma.

@ast

Earlier presentation and application of curative treatments in hepatocellular carcinoma.

@en

Earlier presentation and application of curative treatments in hepatocellular carcinoma.

@nl

prefLabel

Earlier presentation and application of curative treatments in hepatocellular carcinoma.

@ast

Earlier presentation and application of curative treatments in hepatocellular carcinoma.

@en

Earlier presentation and application of curative treatments in hepatocellular carcinoma.

@nl

P1433

Q34416067-7820EA7C-F5CF-4818-8B42-ACE8444E9783

P1476

Q34416067-9C66146D-D32E-4C08-ACD6-5ECE514FA8C3

P2093

Q34416067-204EF956-4C3E-46E7-8102-34E2786FFAF7

Q34416067-3143BC97-DEA6-47D8-B670-9A70392FE3BC

Q34416067-3B359CA0-78B3-4430-B27D-C5F756068AF6

Q34416067-B9F4033D-127C-474E-8E95-A74981EC2DC9

Q34416067-C61D9865-A0B8-4D03-8AFE-A24EADC4B05B

Q34416067-C706A35F-0A35-4A5F-97B6-C62E2763C2E7

Q34416067-D57B3995-02DD-46C9-BFA9-5875C9CE5616

Q34416067-EBDC98DD-C662-4D9F-9B65-5EB842551750

P2860

Q34416067-05BF2CB1-6076-47C7-903F-FE945D44D00A

Q34416067-10A2A3A1-F45E-4B91-8815-0B42DDAFD39B

Q34416067-1579D15F-44D4-4CF3-B8C4-67ABF3FF2DB0

Q34416067-25F9D07A-349A-457D-8AB1-AB48949B710C

Q34416067-2E13B891-DB04-4B44-82C1-599B308CC554

Q34416067-35460C6E-236D-49A1-9ADC-19F3871B9B0E

Q34416067-54BF8AEA-8683-4E79-9B5D-1B627ED5F731

Q34416067-5569BBC7-3A4D-43B1-8C7D-615383AFFEF6

Q34416067-64650AB0-1872-4423-8DDD-64CF8BADA153

Q34416067-66E71FFB-B4EE-43F8-8CE6-9AC27F3E5FBF

P304

Q34416067-03FEF12B-061C-4A28-AB25-CBEE8CB61546

P31

Q34416067-24F6A5F1-698F-4714-8D53-A3BDF122864E

P356

Q34416067-E674C84F-A4C5-4D09-A180-BEB3D50C3DB1

P407

Q34416067-5850D6DC-61B0-49B6-AD1A-6E85984C9BC8

P433

Q34416067-0768B1CB-4C08-4839-A9D3-23AFC6D7BA9B

P478

Q34416067-9C0034F3-728B-46AA-A0F8-4FC58556A199

P50

Q34416067-8133FEC0-11E2-4518-9392-8A9738279D80

P577

Q34416067-05236F61-35DC-4771-8E0C-3FAB1C7813E1

P698

Q34416067-8355CF35-BFE6-42A7-AFA3-C8AA12AFB358

P932

Q34416067-06F4877B-A953-4DBB-AE84-1189AE74E03E

P356

P1433

P1476

Earlier presentation and application of curative treatments in hepatocellular carcinoma

@en

P2093

Austin G Duffy

http://www.w3.org/2001/XMLSchema#string

Jonathan K Kish

http://www.w3.org/2001/XMLSchema#string

Katherine A McGlynn

http://www.w3.org/2001/XMLSchema#string

Lois A Dickie

http://www.w3.org/2001/XMLSchema#string

Osama E Rahma

http://www.w3.org/2001/XMLSchema#string

Sean F Altekruse

http://www.w3.org/2001/XMLSchema#string

Tim F Greten

http://www.w3.org/2001/XMLSchema#string

Timothy S McNeel

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

Management of hepatocellular carcinoma: An update

Sorafenib in advanced hepatocellular carcinoma

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

Management of hepatocellular carcinoma

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

Meta-analysis of radiofrequency ablation versus hepatic resection for small hepatocellular carcinoma.

Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial design.

Failure rates in the hepatocellular carcinoma surveillance process.

P304

1637-1644

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HEP.27288

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

60

http://www.w3.org/2001/XMLSchema#string

P50

Susanna V Ulahannan

P577

2014-09-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24996116

http://www.w3.org/2001/XMLSchema#string

P932

4211986

http://www.w3.org/2001/XMLSchema#string